<DOC>
	<DOCNO>NCT00363337</DOCNO>
	<brief_summary>The specific aim study obtain preliminary evidence acute effectiveness tolerability aripiprazole treatment bipolar depression .</brief_summary>
	<brief_title>A Preliminary Study Effectiveness Tolerability Aripiprazole Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>subject must bipolar I , II NOS disorder define DSMIVTR ; must clinical significant depressive symptom fail one mood stabilizer trial ; may may receive antimanic mood stabilize medication ; subject legally authorize representative must sign Informed Consent document nature trial fully explain ; female , subject must postmenopausal , surgically incapable childbearing practice medically acceptable effective method ( ) contraception . subject bipolar disorder DSMIV criterion ; subject current DSMIV Axis I diagnosis delirium , dementia , amnesia cognitive disorder psychotic disorder ; subject serious general medical illness ; subject allergic demonstrated hypersensitivity aripiprazole ; woman pregnant nursing ; subject receive experimental drug use experimental device within 30 day ; subject history neurologic malignant syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Adults</keyword>
	<keyword>Bipolar Depression</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Bipolar I</keyword>
	<keyword>Bipolar II</keyword>
	<keyword>Depression</keyword>
</DOC>